Prevacus | search
Click here to view Prevacus news from 60+ newspapers.
Bookmark or Share- Prevacus Announces Sale of PRV-002 to Odyssey Group InternationalPrevacus, Inc. is a biopharmaceutical company developing drug candidates with the potential to advance treatment in the fields of traumatic brain injury and other neurological disorders.
- Odyssey Group International to Acquire Concussion Drug Asset from ...Prevacus, Inc. is a biopharmaceutical company developing drug candidates with the potential to advance treatment in the fields of traumatic brain injury and other neurological disorders.
- Prevacus Announces Sale of PRV-002 to Odyssey Group ... - BioSpacePrevacus, Inc., a leading biopharmaceutical company focused on developing treatments for concussion (mild traumatic brain injury (mTBI)) and other neurological disorders; today announced that it has entered into a definitive agreement for the sale of drug candidate PRV-002 to Odyssey Group International (OTCQB:ODYY).
- Prevacus timeline: How a Florida company got Mississippi welfare moneyHere is a timeline of events showing Gov. Phil Bryant's interactions with a Florida drug company linked to a welfare embezzlement scheme.
- Jake VanLandingham spearheads development of concussion drug PrevacusPrevacus is intended to be administered nasally (in a powder form) within minutes after diagnosis of a brain injury. It is designed to treat concussions at the molecular level to trigger the ...
More
